期刊
BIOENGINEERED
卷 13, 期 5, 页码 13108-13117出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21655979.2022.2079244
关键词
MIR22HG; miR-9-3p; prostate cancer; proliferation; apoptosis
资金
- Nantong City Scientific Project [JCZ21079]
- Jiangsu Commission of Health [BJ21010]
This study found that long non-coding RNA MIR22HG is expressed at a low level in prostate cancer cells. MIR22HG overexpression inhibits cell proliferation and promotes apoptosis, possibly by sponging miR-9-3p. These findings are important for the treatment of prostate cancer.
The present study was designed to discuss long non-coding RNA (lncRNA) MIR22HG expression in prostate cancer and to address its effect on prostate cancer cells. MIR22HG and microRNA (miR)-9-3p expressions in prostate cancer cells were examined with the use of quantitative real-time PCR (qRT-PCR). Cell counting kit (CCK)-8, colony formation, and TUNEL were conducted to determine cell viability and apoptosis. Immunofluorescence was employed for the detection of Ki67 expression, and western blotting was applied for the examination of apoptosis-related proteins. The relationship of MIR22HG and miR-9-3p was verified employing luciferase reporter assay. Indeed, low MIR22HG expression was discovered in prostate cancer cells. Subsequently, in vitro loss-of-function studies revealed that MIR22HG overexpression suppressed cell proliferation but promoted cell apoptosis, accompanied with a reduction in Ki67 and Bcl-2 expressions, as well as an elevation in Bax and cleaved caspase 3 expressions. In addition, MIR22HG was identified as a sponge of miR-9-3p and the impacts of MIR22HG overexpression on cell proliferation and apoptosis were partly hindered by miR-9-3p overexpression. In summary, MIR22HG acts as an anticancer gene in prostate cancer via inhibiting cell proliferation and promoting apoptosis by sponging miR-9-3p. This article may provide a novel insight into the treatment of prostate cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据